Use of beta-blockers in non-cardiac surgery: An open debate

Minerva Anestesiologica

Volumn 80, Issue 4, 2014, Pages 482-494

  Sanfilippo, F ^a,b   Santonocito, C ^a   Foex P ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Anemia; Guidelines; Hypotension; Stroke

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO;

BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; DRUG EXPOSURE; DRUG INDICATION; DRUG USE; HEART ARREST; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART RATE; HUMAN; META ANALYSIS (TOPIC); NONCARDIAC SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SEPSIS; SURGICAL RISK; SURGICAL TECHNIQUE; TITRIMETRY; CHEMICALLY INDUCED; HEART DISEASES; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RISK FACTOR; STROKE;

ADRENERGIC BETA-ANTAGONISTS; HEART DISEASES; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE;

EID: 84901457116     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008:372:139-44.
2. Poldermans D, Schouten O, Bax JJ, Winkel TA. Reducing cardiac risk in non-cardiac surgery: evidence form the DECREASE studies. Eur Heart J 2009;11(Suppl. A):A9-A14.
3. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009;361:1368-75.
4. Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:504-10. (Pubitemid 23085792)
5. Shah KB, Kleinman BS, Rao TL, Jacobs HK, Mestan K, Schaafsma M. Angina and other risk (actors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 1990;70:240-7. (Pubitemid 20185106)
6. Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 2011;154:523-8.
7. Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992;268:233-9.
8. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998;88:572-8. (Pubitemid 28120188)
9. Kumar R, McKinney WP, Raj G, Heudebert GR, Heller HJ, Koetting M et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001;16:507-18. (Pubitemid 34203389)
10. London MJ, Zaugg M, Schaub MC, Spahn DR. Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 2004;100:170-5. (Pubitemid 38031669)
11. Suttner S, Boldt J, Mengistu A, Lang K, Mayer J. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients. Br J Anaesth 2009;102:597-607.
12. Yeager RA, Moneta GL, Edwards JM, Taylor LM, McConnell DB, Porter JM. Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. Arch Surg 1995;130:869-72; discussion 72-3.
13. Chopra V, Plaisance B, Cavusoglu E, Flanders SA, Eagle KA. Perioperative beta-blockers for major noncardiac surgery: Primum Non Nocere. Am J Med 2009;122:222-9.
14. Dunzendorfer S, Wiedermann CJ. Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol 2000;32:915-24. (Pubitemid 30663101)
15. Macchia A, Romero M, Comignani PD, Mariani J, D'Ettorre A, Prini N et al. Previous prescription of beta-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 2012;40:2768-72.
16. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123:2434-506.
17. Opie LH. Beta-blockade should not be among several choices for initial therapy of hypertension. J Hypertens 2008;26:161-3.
18. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906. (Pubitemid 41265663)
19. Bangalore S, Parkar S, Grossman E, Messerli FH. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 2007;100:1254-62. (Pubitemid 47498283)
20. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised place-bo-controlled trial. Lancet 2005:366:1622-32.
21. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001;104:1577-9. (Pubitemid 32917355)
22. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-e140.
23. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM et al. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;57:1920-59.
24. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S et al. beta-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012;308:1340-9.
25. Prys Roberts C, Foex P, Biro GP, Roberts JG. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 1973;45:671-81.
26. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988;68:495-500.
27. Pasternack PF, Grossi EA, Baumann FG, Riles TS, Lamparello PJ, Giangola G et al. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 1989;158:113-6. (Pubitemid 19206329)
28. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20. (Pubitemid 26399345)
29. Poldermans D, Boersma E, Bax JJ, Thomson IR, van-de-Ven LL, Blankensteijn JD et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94.
30. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997;127:313-28. (Pubitemid 27352055)
31. Devereaux PJ, Yusuf S, Yang H, Choi PT-L, Guyatt GH. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ 2004;171:245-7. (Pubitemid 39061590)
32. Eagle KA, Berger PB, Calkins H, Chairman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67. (Pubitemid 34225832)
33. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 1996;27:910-48.
34. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005;41:602-9. (Pubitemid 40637658)
35. Juul AB, Wetterslev J, Kofoed Enevoldsen A, Callesen T, Jensen G, Gluud C. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: Rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Am Heart J 2004;147:677-83. (Pubitemid 38900458)
36. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006;152:983-90. (Pubitemid 44632958)
37. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 2006;113:2662-74.
38. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007;116:1971-96.
39. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47.
40. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008;372:1962-76.
41. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions; 2011. [cited 2014 February 25]. Available at: http://www.cochrane.org/training/cochranehandbook
42. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009;120:e169-276.
43. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769-812.
44. Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921-6.
45. Center EM. Erasmus MC dismisses professor, [cited 2014 February 24]. Available at: http://erasmusmc.nl/ corp-home/corp-news-center/2011 /2011-11/ontslag. hoogleraar/?lang=en
46. Center EM. Report of the 2012 follow-up investigation of possible breaches of academic integrity. 2012.
47. Poldermans D. Scientific fraud or a rush to judgment? Am J Med 2013;126:e5-6.
48. Chopra V, Eagle KA. Perioperative mischief: the price of academic misconduct. Am J Med 2012;125:953-5.
49. Boutonnet M, De Saint Maurice G, Cottez Gacia S, Ausset S. Perioperative beta-blockade: how long does the perioperative period last? Acta Anaesthesiol Scand 2009;53:1100-1.
50. Poldermans D, Devereaux PJ. The experts debate: perioperative beta-blockade for noncardiac surgery - proven safe or not? Cleve Clin J Med 2009;76(Suppl 4):S84-92.
51. van Lier F, Schouten O, van Domburg RT, van der Geest PJ, Boersma E, Fleisher LA et al. Effect of chronic beta-blocker use on stroke after noncardiac surgery. Am J Cardiol 2009;104:429-33.
52. van Lier F, Schouten O, Hoeks SE, van de Ven L, Stolker RJ, Bax JJ et al. Impact of prophylactic beta-blocker therapy to prevent stroke after noncardiac surgery. Am J Cardiol 2010;105:43-7.
53. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-6. (Pubitemid 23173023)
54. Le Manach Y, Collins GS, Ibanez C, Goarin JP, Coriat P, Gaudric J et al. Impact of perioperative bleeding on the protective effect of beta-blockers during infrarenal aortic reconstruction. Anesthesiology 2012;117:1203-11.
55. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G, Mitsakakis N et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010;112:25-33.
56. van Klei WA, Bryson GL, Yang H, Forster AJ. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology 2009;111:717-24.
57. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007;116:471-9.
58. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117:478-84.
59. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) 1988;296:737-41. (Pubitemid 18066502)
60. De Raedt S, Haentjens P, De Smedt A, Brouns R, Uyttenboogaart M, Luijckx GJ et al. Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome. Eur J Neurol 2012;19:234-40.
61. Wang TJ, Levy D, Benjamin EJ, Vasan RS. The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 2003:138:907-16.
62. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, Kitzman DW et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-9. (Pubitemid 35176095)
63. Morgan S, Smith H, Simpson I, Liddiard GS, Raphael H, Pickering RM et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ 1999;318:368-72. (Pubitemid 29192086)
64. Kempen PM. Time to change the paradigm? Which paradigm? Acta Anaesthesiol Scand 2009;53:1099-100.
65. Badgett RG, Lawrence VA, Cohn SL. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology 2010;113:585-92.
66. Shin J, Johnson JA. Pharmacogenetics of beta-blockers. Pharmacotherapy 2007;27:874-87.
67. Goryachkina K, Burbello A, Boldueva S, Babak S, Bergman U, Bertilsson L. CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction. Eur J Clin Pharmacol 2008;64:1163-73.
68. Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK et al. 2009 ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 2009;54:2102-28.
69. Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 2010;113:794-805.
70. Karachalios GN, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK et al. Withdrawal syndrome following cessation of antihypertensive drug therapy. Int J Clin Pract 2005;59:562-70. (Pubitemid 41632462)
71. Frishman WH. Beta-adrenergic blocker withdrawal. Am J Cardiol 1987;59:26F-32F. (Pubitemid 17089223)
72. Hoeks SE, Scholte Op Reimer WJ, van Urk H, Jorning PJ, Boersma E, Simoons ML et al. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vase Endovasc Surg 2007;33:13-9. (Pubitemid 44849344)
73. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. (Pubitemid 29416229)
74. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148-53. (Pubitemid 32061325)
75. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G. Beta-Blockers Reduce Mortality in Patients Undergoing High-Risk Non-Cardiac Surgery. Am J Cardiovasc Drugs 2010;10:247-59.
76. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008;106:1039-48, table of contents. (Pubitemid 351450524)
77. Aronson JK. Changing beta-blockers in heart failure: when is a class not a class? The British J Gen Pract 2008;58:387-9. (Pubitemid 351780892)
78. Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: A double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007:107:33-44.
79. Ellenberger C, Tait G, Beattie WS. Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: a single-center propensity-matched cohort study. Anesthesiology 2011;114:817-23.
80. Wallace AW, Au S, Cason BA. Perioperative beta-blockade: atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011;114:824-36.
81. Redelmeier D, Scales D, Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 2005:331:932.
82. Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnocchi-Ruscone T et al Clinical effiocacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective randomized, placebo-controlled, double-blind crossover evaluation. J Am Coll Cardiol 2012;60:1323-9.
83. Landoni G, Turi S, Biondi-Zoccai G, Bignami E, Testa V, Belloni I et al. Esmolol reduces perioperative ischemia in noncardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009;24:219-29.
84. Ausset S, Auroy Y, Lambert E, Vest P, Plotton C, Rigal S et al. Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anaesth 2008;25:158-64.
85. Oscarsson A, Eintrei C, Anskar S, Engdahl O, Fagerstrom L, Blomqvist P et al. Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery. Acta Anaesthesiol Scand 2004;48:1071-9. (Pubitemid 39274122)
86. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61. (Pubitemid 41132339)
87. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013;309:1704-13.
88. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Repaci S, del Pinto M et al. Beta-blockers and risk of all-cause mortality in non-cardiac surgery. Ther Adv Cardiovasc Dis 2010;4:109-18.
89. Angeli F, Verdecchia P, Del Pinto M, Cavallini C, Reboldi G. Perioperative beta blockade: the debate continues. Lancet 2009:373:627; author reply 8.
90. Wijeysundera DN, Mamdani M, Laupacis A, Fleisher LA, Beattie S, Johnson SR et al. Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery. Circ Cardiovasc Qual Outcomes 2012;5:558-65.
91. (POISE-2) PIEt-. clinicaltrials.gov/ct2/show/NCT01082874